{{Rsnum
|rsid=3768716
|Gene=BARD1
|Chromosome=2
|position=214771070
|Orientation=minus
|GMAF=0.1442
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Summary=increases the odds of aggressive neuroblastoma
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BARD1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 57.5 | 36.3 | 6.2
| HCB | 73.7 | 22.6 | 3.6
| JPT | 58.4 | 40.7 | 0.9
| YRI | 95.9 | 4.1 | 0.0
| ASW | 86.0 | 14.0 | 0.0
| CHB | 73.7 | 22.6 | 3.6
| CHD | 72.5 | 26.6 | 0.9
| GIH | 56.0 | 36.0 | 8.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 55.2 | 41.4 | 3.4
| MKK | 97.4 | 2.6 | 0.0
| TSI | 69.6 | 27.5 | 2.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19412175
|Title=Common variations in [[BARD1]] influence susceptibility to high-risk [[neuroblastoma]]
|OA=1
}}

[http://blog.23andme.com/2009/05/06/snpwatch-researchers-identify-genetic-variations-associated-with-aggressive-neuroblastoma/ 23andMe blog] Each copy of a G at this SNP increases the odds of aggressive [[neuroblastoma]] by 1.68 times.

allelic odds ratio of 1.68 (p = 2.74 x 10(-16))

{{omim
|id=256700
|desc=NEUROBLASTOMA
|rsnum=3768716
}}

{{PMID Auto GWAS
|PMID=21124317
|Trait=None
|Title=Integrative genomics identifies LMO1 as a neuroblastoma oncogene
|RiskAllele=C
|Pval=5E-13
|OR=1.3860
|ORtxt=[NR]
|OA=1
}}
{{omim
|id=613016
|rsnum=3768716
}}

{{PMID|18463370|OA=1
}} Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}